# Biomat USA Inc – FDA Inspection, Sep 17, 2014

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ac8bbbe0-cdc4-45ca-adca-f0fe6adfbaf2
Source feed: FDA_Inspections

> FDA inspection 896180 of Biomat USA Inc, September 17, 2014. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 606 and 640. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 896180
- Company Name: Biomat USA Inc
- Inspection Date: 2014-09-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1049586 - 2018-02-15
- FDA Inspection 985568 - 2016-05-20
- [FDA Inspection 746815 - 2011-09-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e16e29e3-1ccb-4b62-a639-68d55150a762)
- [FDA Inspection 576969 - 2009-04-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d0326678-bffe-46c6-91f4-bd4b51f9c5e7)

Company: https://www.keypedia.com/companies/biomat-usa-inc/8d621cff-bb83-4bf9-8740-84c1c10acad6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d